Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Robbins

Showing results (131-140 of 258) with videos related to

Pageof 26
Sort By:
Cancer Research|April 19, 2007
Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bondCyrille J Cohen, Yong F Li, Mona El-Gamil, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1996
Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residuesM R Parkhurst, M L Salgaller, S Southwood, et al.
The Journal of Experimental Medicine|March 1, 1996
A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytesP F Robbins, M El-Gamil, Y F Li, et al.
Immunogenetics|January 1, 1997
Diversity associated with the second expressed HLA-DRB locus in the human populationF Robbins, C K Hurley, T Tang, et al.
Human Pathology|December 3, 2013
Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanomaPhyu P Aung, Yen-Chun Liu, Leomar Y Ballester, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1995
Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognitionE J Stevens, L Jacknin, P F Robbins, et al.
Cancer Gene Therapy|October 19, 2002
MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cellsJ Mark Sloan, Michael H Kershaw, Christopher E Touloukian, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Irradiation enhances human T-cell function by upregulating CD70 expression on antigen-presenting cells in vitroJianping Huang, Qiong J Wang, Shicheng Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2013
Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapySimon Turcotte, Alena Gros, Eric Tran, et al.
The Journal of Experimental Medicine|July 1, 1994
Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytesY Kawakami, S Eliyahu, K Sakaguchi, et al.
Pageof 26

Showing results (131-140 of 258) with videos related to

Sort By:
Pageof 26
Cancer Research|April 19, 2007
Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bondCyrille J Cohen, Yong F Li, Mona El-Gamil, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1996
Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residuesM R Parkhurst, M L Salgaller, S Southwood, et al.
The Journal of Experimental Medicine|March 1, 1996
A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytesP F Robbins, M El-Gamil, Y F Li, et al.
Immunogenetics|January 1, 1997
Diversity associated with the second expressed HLA-DRB locus in the human populationF Robbins, C K Hurley, T Tang, et al.
Human Pathology|December 3, 2013
Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanomaPhyu P Aung, Yen-Chun Liu, Leomar Y Ballester, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1995
Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognitionE J Stevens, L Jacknin, P F Robbins, et al.
Cancer Gene Therapy|October 19, 2002
MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cellsJ Mark Sloan, Michael H Kershaw, Christopher E Touloukian, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Irradiation enhances human T-cell function by upregulating CD70 expression on antigen-presenting cells in vitroJianping Huang, Qiong J Wang, Shicheng Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2013
Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapySimon Turcotte, Alena Gros, Eric Tran, et al.
The Journal of Experimental Medicine|July 1, 1994
Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytesY Kawakami, S Eliyahu, K Sakaguchi, et al.
Pageof 26